13FBOX
Lynx1 Capital Management LP · 13F 持仓分析
期权收益计算器 机构排行

Lynx1 Capital Management LP

No.4206 数据截至 2026Q2
最新持仓市值 (Q2 2026)
$5.08亿
环比变动 Q1 2026
-$1.25亿-19.8%
持仓股票数
23
新买入
6
加仓
4
减仓
6
清仓
6
持股不变
7
持仓市值走势图
持仓板块构成
股票 历史所有权投资组合占比上一季度占比Q2 2026 市值Q2 2026 股数上季度市值上季度股数股数变动操作
CCULLINAN THERAPEUTICSCGEM
32.16%20.13%$1.63亿896.4万股$1.27亿896.4万股00.00%持仓不变
STOKE THERAPEUTICSSTOK
26.03%24.51%$1.32亿403.8万股$1.55亿476.4万股-72.5万股-15.22%减仓
AGIOS PHARMACEUTICALSAGIO
24.92%13.96%$1.27亿340.9万股$8,834.9万261.2万股+79.7万股+30.53%加仓
CC4 THERAPEUTICS INC COM STKCCCC
6.74%2.91%$3,421.6万732.7万股$1,840.7万699.9万股+32.8万股+4.68%加仓
KORRO BIOKRRO
3.99%2.75%$2,027.5万153.8万股$1,741.4万153.8万股00.00%持仓不变
TTSCAN THERAPEUTICS INC COMTCRX
1.55%1.28%$786.0万801.9万股$809.9万801.9万股00.00%持仓不变
PPRECISION BIOSCIENCES INCORPORATED COM NEWDTIL
1.47%0.86%$747.1万95.0万股$541.8万98.5万股-3.5万股-3.52%减仓
NNEUPHORIA THERAPEUTICS INCNEUP
0.75%0.56%$382.5万87.5万股$356.3万87.5万股00.00%持仓不变
PPASSAGE BIOPASG
0.65%0.77%$328.8万67.4万股$489.6万62.4万股+5.0万股+8.03%加仓
CG ONCOLOGYCGON
0.44%0.34%$223.0万3.1万股$213.8万3.2万股-200股-0.63%减仓
PPLIANT THERAPEUTICSPLRX
0.4%$205.0万179.8万股$00股+179.8万股新买入
ENTRADA THERAPEUTICS INC COMTRDA
0.26%0.42%$131.5万17.9万股$267.2万21.2万股-3.3万股-15.63%减仓
VVYNE THERAPEUTICS INCMNLOUSD
0.21%0.15%$106.0万162.9万股$97.3万162.9万股00.00%持仓不变
TTRAWS PHARMA INCTRAW
0.09%<0.01%$47.2万55.9万股$2.8万1.5万股+54.4万股+3,610.51%加仓
FFOGHORN THERAPEUTICSFHTX
0.06%$30.1万6.2万股$00股+6.2万股新买入
DENALI THERAPEUTICSDNLI
0.06%5.71%$30.0万1.2万股$3,610.2万188.0万股-186.9万股-99.38%减仓
XXENCORXNCR
0.06%1.02%$29.3万1.8万股$646.9万53.6万股-51.8万股-96.61%减仓
WWEREWOLF THERAPEUTICS INC COMHOWL
0.05%0.09%$23.7万65.8万股$54.8万65.8万股00.00%持仓不变
AVALO THERAPEUTICSAVTX
0.04%$18.7万1.0万股$00股+1.0万股新买入
BBOLT BIOTHERAPEUTICS INCBOLT
0.02%0.02%$11.9万3.1万股$12.4万3.1万股00.00%持仓不变
NNUVATION BIONUVB
0.02%$9.1万1.6万股$00股+1.6万股新买入
EUPRAXIA PHARMACEUTICALSEPRX
0.01%$6.6万1.0万股$00股+1.0万股新买入
IINHIBIKASE THERAPEUTICS INC COM NEWIKT
0.01%$4.1万2.0万股$00股+2.0万股新买入

🧭 机构资金流板块热力图

净流出 净流入